Alvotech Files October 2024 Report on Form 6-K

Ticker: ALVOW · Form: 6-K · Filed: Oct 22, 2024 · CIK: 1898416

Alvotech 6-K Filing Summary
FieldDetail
CompanyAlvotech (ALVOW)
Form Type6-K
Filed DateOct 22, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, foreign-private-issuer

TL;DR

Alvotech filed its monthly 6-K, confirming 20-F annual report filings. Standard procedure.

AI Summary

Alvotech, a biopharmaceutical company, filed a Form 6-K on October 22, 2024, to report its activities for the month of October 2024. The filing indicates that Alvotech is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive office is located in Luxembourg.

Why It Matters

This filing provides routine updates on Alvotech's corporate activities as a foreign private issuer, which is important for investors tracking the company's compliance and reporting schedule.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain material financial or operational news.

Key Numbers

  • 001-41421 — SEC File Number (Identifies the specific filing with the SEC)

Key Players & Entities

  • Alvotech (company) — Registrant
  • 001-41421 (dollar_amount) — SEC File Number
  • 20241022 (date) — Filing Date
  • Luxembourg (company) — Principal Executive Office Location

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.

What type of company is Alvotech?

Alvotech is identified as a foreign private issuer and operates in the Biological Products (No Diagnostic Substances) industry.

When was this Form 6-K filed?

This Form 6-K was filed on October 22, 2024.

Where is Alvotech's principal executive office located?

Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

Does Alvotech file annual reports under Form 20-F or 40-F?

Alvotech indicates that it files annual reports under cover of Form 20-F.

Filing Stats: 340 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2024-10-22 07:00:06

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: October 22, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.